| R million | Notes |
30 June 2017 |
30 June 2016 Restated* |
|---|---|---|---|
| Sales | 27 600 | 27 697 | |
| Inventory expenses | (16 138) | (16 959) | |
| Staff costs | (4 972) | (4 578) | |
| Depreciation | (752) | (727) | |
| Other net operating expenses | (4 978) | (4 921) | |
| Trading profit | 760 | 512 | |
| Dividend income | 61 | 77 | |
| Interest received | 633 | 287 | |
| Fair value adjustment on exchangeable bonds’ option* | 687 | (730) | |
| Finance costs | (1 255) | (903) | |
| Net impairment of investments, loans, assets and goodwill | 105 | (2 556) | |
| Profit on sale and dilution of investments | 199 | 2 451 | |
| Consolidated profit/(loss) before tax | 1 190 | (862) | |
| Taxation | (227) | 21 | |
| Consolidated profit/(loss) after tax | 963 | (841) | |
| Share of after-tax profit of equity accounted investments | 11 | 7 545 | 6 250 |
| Net profit for the year | 8 508 | 5 409 | |
| Attributable to: | |||
| Equity holders | 8 431 | 5 364 | |
| Non-controlling interest | 77 | 45 | |
| 8 508 | 5 409 | ||
* For details of the restatement refer to note 15.
